Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Si-Qi Q"'
Autor:
Wen-Qi Shi, Dan-Xun Chen, Ze-Sen Du, Chun-Peng Liu, Tian-Tian Zhai, Feng Pan, Hai-Lu Chen, Wei-Nan Liao, Shao-Hong Wang, Jun-Hui Fu, Si-Qi Qiu, Zhi-Yong Wu
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Immune checkpoint blockade (ICB) has been improving the patient outcome in multiple cancer types. However, not all patients respond to ICB. Biomarkers are needed for selecting appropriate patients to receive ICB. CD74 is an import
Externí odkaz:
https://doaj.org/article/163e9eee5dac44ce8b960c7d71031893
Autor:
Yi-Chao Chen, Wei-Zhong Zheng, Chun-Peng Liu, Yong-Qiang Zhao, Jun-Wei Li, Ze-Sen Du, Tian-Tian Zhai, Hao-Yu Lin, Wen-Qi Shi, Shan-Qing Cai, Feng Pan, Si-Qi Qiu
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Currently, there are no optimal biomarkers available for distinguishing patients who will respond to immune checkpoint inhibitors (ICIs) therapies. Consequently, the exploration of novel biomarkers that can predict responsiveness
Externí odkaz:
https://doaj.org/article/9ac3cb8cd59b4399be13a7a64c025086
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-32 (2023)
Abstract Targeted anticancer drugs block cancer cell growth by interfering with specific signaling pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing cells as in cytotoxic chemotherapy. The Response Evaluation
Externí odkaz:
https://doaj.org/article/18034cb271c74c9da07e07b947dac2e1
Publikováno v:
Journal of Medical Diagnostic Methods.
Three patients with gastric adenocarcinoma, endometrial cancer and pancreatic head cancer respectively were treated medications including herbal regimens. The clinical outcomes were followed. These regimens were effective. The patients were able to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e772217942dc5f63cd5922b3790c1e1
https://doi.org/10.4172/2168-9784.1000183
https://doi.org/10.4172/2168-9784.1000183
Autor:
Frans V. Suurs, Si-Qi Qiu, Joshua J. Yim, Carolien P. Schröder, Hetty Timmer-Bosscha, Eric S. Bensen, John T. Santini, Elisabeth G. E. de Vries, Matthew Bogyo, Gooitzen M. van Dam
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Purpose The reoperation rate for breast-conserving surgery is as high as 15–30% due to residual tumor in the surgical cavity after surgery. In vivo tumor-targeted optical molecular imaging may serve as a red-flag technique to improve intra
Externí odkaz:
https://doaj.org/article/ceaecad9b3c5412ab04b67bef8375d0d
Autor:
Si-Qi Qiu, Johan van Rooijen, Hilde H. Nienhuis, Bert van der Vegt, Hetty Timmer-Bosscha, Elise van Leeuwen-Stok, Annemiek M. E. Walenkamp, Carolien H. M. van Deurzen, Geertruida H. de Bock, Elisabeth G. E. de Vries, Carolien P. Schröder
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background Breast cancer is rare in men, but management is focused on tumor characteristics commonly found in female breast cancer. The tumor microenvironment of male breast cancer is less well understood, and insight may improve male breast
Externí odkaz:
https://doaj.org/article/6dac41f9d188433fb23a4a389a57ad75
Autor:
Li-Yun Xie, Kun Wang, Hai-Lu Chen, Yan-Xia Shi, Yuan-Qi Zhang, Hao-Yu Lin, Yuan-Ke Liang, Ying-Sheng Xiao, Zhi-Yong Wu, Zhong-Yu Yuan, Si-Qi Qiu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPatients who achieve a tumor pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) have better outcomes than patients with residual tumor. However, tumors still recur in the pCR patients. Therefore, we aim to explore facto
Externí odkaz:
https://doaj.org/article/529ebebf407249008a4a9dc9b27a3c30
Autor:
Yuan-ke Liang, Ze-kun- Deng, Mu-tong Chen, Si-qi Qiu, Ying-sheng Xiao, Yu-zhu Qi, Qin Xie, Zheng-hao Wang, Shi-cheng Jia, De Zeng, Hao-yu Lin
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The chemokine CXCL9 (C-X-C motif chemokine ligand 9) has been reported to be required for antitumour immune responses following immune checkpoint blockade. In this study, we sought to investigate the potential value of CXCL9 according to immune respo
Externí odkaz:
https://doaj.org/article/cc1023860af3498388348b4727a9ac42
Autor:
Marjory Koller, Si-Qi Qiu, Matthijs D. Linssen, Liesbeth Jansen, Wendy Kelder, Jakob de Vries, Inge Kruithof, Guo-Jun Zhang, Dominic J. Robinson, Wouter B. Nagengast, Annelies Jorritsma-Smit, Bert van der Vegt, Gooitzen M. van Dam
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Fluorescent tracers are being tested in clinical trials to improve detection of tumor margins, but procedures are not standardised. Here, the authors develop an analytical framework that is compatible with the workflow in the operating theatre, and s
Externí odkaz:
https://doaj.org/article/3ed830983e42469387cbdb1c666bbe45
Autor:
Yong-Qu Zhang, Xiao-Long Wei, Yuan-Ke Liang, Wei-Ling Chen, Fan Zhang, Jing-Wen Bai, Si-Qi Qiu, Cai-Wen Du, Wen-He Huang, Guo-Jun Zhang
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135851 (2015)
Overexpression of Twist, a highly conserved basic helix-loop-helix transcription factor, is associated with epithelial-mesenchymal transition (EMT) and predicts poor prognosis in various kinds of cancers, including breast cancer. In order to further
Externí odkaz:
https://doaj.org/article/d30acbc63ea142f7a84eed7ed938c3a7